Sun Pharma Advanced Research to garner up to Rs 1,800 crore

[ad_1]


The purpose for the fund-raising was not immediately disclosed. In its meeting on Wednesday, SPARC’s board also approved increasing the company’s authorised share capital to Rs 42.50 crore from the present Rs 37.50 crore.

[ad_2]

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *